Navigation Links
Chindex International, Inc. Reports First Quarter 2011 Financial Results
Date:5/9/2011

CML) between FosunPharma and Chindex International began operations on January 1, 2011. The strategic venture merged the former Medical Products division of Chindex International and select medical device companies of FosunPharma. FosunPharma owns 51% and Chindex owns 49% of the CML joint venture. Beginning this quarter, Chindex has deconsolidated CML's operating results and recognizes its 49% interest in CML's net income using the equity method of accounting.

Accordingly, in the first quarter of 2011, other expenses include a $147,000 loss for Chindex's 49% share of the net loss of CML for the quarter.  On a stand-alone basis, the CML joint venture had a net loss of $37,000 for the quarter, which included a stock-based compensation expense charge of $279,000. In recognizing its 49% interest in the net income of CML for the quarter, Chindex also included additional expenses for amortization of certain fair value adjustments made in connection with the formation of the joint venture. CML results in the first quarter of 2011 reflected the weakest budgeted quarter for the joint venture. The Company expects improved results in future quarters which are anticipated to offset the stock-based compensation expense and recurring amortization charges.

The deconsolidation of CML's financial results include the following impacts on the Company's presentation of results:

  • Cost of goods sold, which previously reflected the Medical Products division costs, are no longer broken out on the income statement;
  • Depreciation and amortization expenses, previously consolidated within healthcare services costs, will now be presented as a separate operating expense item to provide greater clarity into the Company's hospital and clinic assets; and
  • General and administrative expenses, which previously included corporate expense and was allocated between both Healthcare Services and Medical Products divisions, is now included in other operating expen
    '/>"/>

    • SOURCE Chindex International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
    2. Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results
    3. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
    4. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
    5. Chindex International to Present at Piper Jaffray Health Care Conference
    6. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
    7. Chindex International to Report First Quarter 2011 Financial Results
    8. Fosun Pharma Acquires $14 Million of Chindex Stock
    9. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2011 Financial Results
    10. Chindex and Fosun Pharma Form Joint Venture
    11. Chindex International to Report Financial Results for the Three and Nine-Month Periods Ended December 31, 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...
    (Date:5/23/2013)... THOUSAND OAKS, Calif. , May 23, 2013 ... Deutsche Bank 38 th Annual  Healthcare Conference on Thursday, ... Boston , beginning at 9:20 a.m. Eastern Daylight ... Investor Relations at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
    (Date:5/23/2013)... RIVER EDGE, N.J. , May 23, 2013 /PRNewswire/ ... ), a commercial stage medical device company that develops ... the successful completion of its rights offering.  In addition, ... company,s March 2011 warrants expired on May 17, 2013. ... proceeds of $3.0 million from the rights offering.   A ...
    Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
    ... More,Efficiently than Male Cells, PITTSBURGH, April 09, 2007 /PRNewswire/ ... ability to regenerate skeletal,muscle tissue than male cells, according ... , The study, which is being published in the ... the first ever to report a difference,in regenerative capabilities ...
    ... BEVERLY, Mass.--(BUSINESS WIRE)--Apr 10, 2007 - Inotek,Pharmaceuticals Corporation ... preclinical animal data showing that the,administration of a ... on the survival of certain brain,cells following a ... the,repair of damaged DNA via the activation and ...
    Cached Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3
    (Date:5/25/2013)... 25, 2013 On May 20, 2013 the ... not wish to discuss or plan for their eventual demise, ... FuneralFinancials.com released a Must-Do List to help people properly ... recommends, “Creating a personal fact sheet.” , While not a ... information and personal data. It may include a summary ...
    (Date:5/25/2013)... 2013 The latest report from ... bowel syndrome (IBS) to bloating, constipation, diarrhea and ... long-lasting, embarrassing, frustrating and difficult health issues to ... health have provided a cure for these ... contributing to digestive health issues, a healthy diet ...
    (Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
    (Date:5/25/2013)... May 25, 2013 Many orthodontists have ... wonder where exactly that cloud is. Most people ... up with to provide their cloud service and support ... provide the service they're selling, they'd be wrong. ... (a secure, redundant facility that houses servers and ...
    (Date:5/25/2013)... May 25, 2013 According to world-renowned ... beautiful and powerful women that ever lived. Cleopatra’s legendary ... some of the most powerful men in her time. ... remedies to keep her skin glowing and fresh, from ... bees- wax, maringa oil and cyprus grass. , Cleopatra ...
    Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
    ... of Vaccines and Biological Products, has announced that it ... vaccine for// humans from chick embryos. ,The ... cockerels and similar reactions were observed.The observations have been ... and Biological Products. Its reported that the quality was ...
    ... journal Obesity looked into 100 overweight children aged 7 to ... or// had other sleep-related breathing problems, reported the online edition ... split the kids into three groups. One group got 40 ... soccer or jump rope - every day for about 13 ...
    ... study shed light on a nagging mystery in neurobiology: why ... of free zinc ions. Zinc - a new key player ... in the brain and spinal cord – says the research. ... a neuronal zinc target, researchers have demonstrated a central role ...
    ... patient's muscles to involuntary contract with movement, has had a ... This new treatment is found to be more effective for ... past. It has relieved the symptoms that sometimes force patients ... studies that a certain type dystonia has a dramatic response ...
    ... by China-Hong Kong experts concluded that there is a genetic ... SARS is transmitted to human beings through// civet cats. The ... Thursday. ,The research that was carried out ... and Protection in Beijing and Guangzhou, in cooperation with the ...
    ... new vaccine that promises protection against a wide range of ... a cell-based technology in 11 weeks time.The vaccine is capable ... virus. ,It is still in the early phase of clinical ... detected in many countries. It has caused maximum damage in ...
    Cached Medicine News:Health News:Zinc – A New Key Player In Brain Circuitr 2
    The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
    ... Notes is a quick-lookup reference for ... pocket guide presents the basics (anatomy ... electrical conduction system of the heart, ... and CPR algorithms, emergency medications, and ...
    ... Cochrane Reviews enable all those involved ... date with the very latest evidence in ... which becomes harder each year as the ... this problem by delivering the best single ...
    ... CVMstat® provides leading ... of topics involving all ... including sections on diagnosis ... arterial and venous disease. ...
    Medicine Products: